Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCV8B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,047
Award facts
- Contract value 100% obligated
- $38,047.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $38,047.13 delivery order to AmerisourceBergen Drug Corp for the supply of Wegovy 1 mg/0.5 mL pens on December 19, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price contract, which carries no set-aside designation, was competitively awarded through DLA's established procurement channels. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime vehicle designated SPE2DX and running through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs.
As a major pharmaceutical distributor, AmerisourceBergen maintains a substantial portfolio of federal medical supply contracts with the DLA Medical Supply Chain, delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This Wegovy delivery order represents a routine pharmaceutical procurement within the company's established federal contract framework, demonstrating its continued capability to fulfill federal medical supply requirements through competitive procurement. The DLA Troop Support is actively planning next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with anticipated multiple regional awards involving at least three contractors, positioning AmerisourceBergen as a key vendor within the broader federal pharmaceutical procurement strategy.
Quick answers
Who was awarded contract SPE2DR26FCV8B?
SPE2DR26FCV8B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FCV8B worth?
The government has obligated $38,047 on SPE2DR26FCV8B.
Is contract SPE2DR26FCV8B an order under another contract?
Yes. SPE2DR26FCV8B is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCV8B competed?
The extent of competition for SPE2DR26FCV8B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award